{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:02:07Z","timestamp":1792785727893,"version":"4.5.0"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Campus Research Project of Hubei University of Science and Technology","award":["2016-19XB01"],"award-info":[{"award-number":["2016-19XB01"]}],"id":[{"id":"https:\/\/ror.org\/018wg9441","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ejmech.2018.01.078","type":"journal-article","created":{"date-parts":[[2018,2,4]],"date-time":"2018-02-04T02:39:30Z","timestamp":1517711970000},"page":"599-612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":369,"special_numbering":"C","title":["Ciprofloxacin derivatives and their antibacterial activities"],"prefix":"10.1016","volume":"146","author":[{"given":"Gui-Fu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baofeng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.01.078_bib1","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ejmech.2017.06.058","article-title":"Ciprofloxacin-nitroxide hybrids with potential for biofilm control","volume":"138","author":"Verderosa","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib2","series-title":"Guidelines for the Management of Drug-resistant Tuberculosis WHO\/TB\/96-210 (Rev.1)","year":"1997"},{"key":"10.1016\/j.ejmech.2018.01.078_bib3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejmech.2017.09.050","article-title":"4-Quinolone hybrids and their antibacterial activities","volume":"141","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejmech.2017.07.059","article-title":"Recent advances of pyrazole-containing derivatives as anti-tubercular agents","volume":"139","author":"Xu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejmech.2017.05.004","article-title":"Recent developments of coumarin-containing derivatives and their anti-tubercular activity","volume":"136","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejmech.2017.04.002","article-title":"Isoniazid derivatives and their anti-tubercular activity","volume":"133","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejmech.2017.06.051","article-title":"Triazole derivatives and their anti-tubercular activity","volume":"138","author":"Zhang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib8","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1016\/j.bmcl.2015.06.041","article-title":"Design and biological evaluation of novel quinolone-based metronidazole derivatives as potent Cu2+ mediated DNA-targeting antibacterial agents","volume":"25","author":"Zhang","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib9","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.bmcl.2006.11.055","article-title":"Newer tetracycline derivatives: synthesis, anti-HIV, antimycobacterial activities and inhibition of HIV-1 integrase","volume":"17","author":"Sriram","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejmech.2017.07.061","article-title":"Quinoline hybrids and their antiplasmodial and antimalarial activities","volume":"139","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib11","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3109\/14756366.2015.1069288","volume":"31","author":"Abdel-Aziz","year":"2016","journal-title":"J.\u00a0Emzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib12","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.1016\/j.bmc.2007.07.009","article-title":"Identification, biological activity, and mechanism of the anti-ischemic quinolone analog","volume":"15","author":"Park","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib13","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1134\/S1070363214090370","article-title":"New isatin acylhydrazones containing sterically hindered phenolic fragments","volume":"84","author":"Bogdanov","year":"2014","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib14","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3390\/molecules22081352","article-title":"Sulfonamide-linked ciprofloxacin, sulfadiazine and amantadine derivatives as a novel class of inhibitors of jack bean urease; synthesis, kinetic mechanism and molecular docking","volume":"22","author":"Channar","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.01.078_bib15","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1016\/j.bmcl.2008.08.109","article-title":"Synthesis and biodistribution of a novel 99mTcN complex of ciprofloxacin dithiocarbamate as a potential agent for infection imaging","volume":"18","author":"Zhang","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/cbdd.12701","article-title":"68Ga-labeled ciprofloxacin conjugates as radiotracers for targeting bacterial infection","volume":"87","author":"Satpati","year":"2016","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2018.01.078_bib17","article-title":"Fluorescent-Labeled amino acid-antibiotic conjugates","volume":"46","author":"Tiwari","year":"2014","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2018.01.078_bib18","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1016\/j.bmcl.2010.04.057","article-title":"Synthesis and biological evaluation of a novel 99mTc(CO)3 complex of ciprofloxacin dithiocarbamate as a potential agent to target infection","volume":"20","author":"Zhang","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib19","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1086\/432803","article-title":"System, Overview of nosocomial infections caused by gram-negative bacilli","volume":"41","author":"Weinstein","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2018.01.078_bib20","doi-asserted-by":"crossref","first-page":"16570","DOI":"10.3390\/ijms140816570","article-title":"Development of quorum-based anti-virulence therapeutics targeting gram-negative bacterial pathogens","volume":"14","author":"Tay","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2018.01.078_bib21","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1021\/jm0510023","article-title":"Hybrid antibacterials. DNA polymerase-topoisomerase inhibitors","volume":"49","author":"Zhi","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib22","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.bmcl.2012.12.045","article-title":"Synthesis and antibacterial evaluation of a novel tricyclic oxaborole-fused fluoroquinolone","volume":"23","author":"Li","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib23","first-page":"199","article-title":"Synthesis and antimicrobial studies of some 4-Thiazolidinone containing Fluoroquinolones analogous","volume":"1","author":"Patel","year":"2009","journal-title":"Der. Pharma. Chem"},{"key":"10.1016\/j.ejmech.2018.01.078_bib24","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00044-009-9228-2","article-title":"Synthesis and antimicrobial study of fluoroquinolone based 4-thiazolidinones","volume":"19","author":"Patel","year":"2010","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.01.078_bib25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.5012\/bkcs.2011.32.2.483","article-title":"Synthesis, characterization and biological evaluations of ciprofloxacin carboxamide analogues","volume":"32","author":"Sultana","year":"2011","journal-title":"Bull. Kor. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.01.078_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/157340610791321442","article-title":"Design of ciprofloxacin derivatives that inhibit growth of methicillin resistant Staphylococcus aureus (MRSA) and methicillin susceptible Staphylococcus aureus (MSSA)","volume":"6","author":"Bartzatt","year":"2010","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib27","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1021\/jm040204g","article-title":"Synthesis and antibacterial activity of the 4-Quinolone-3-carboxylic acid derivatives having a trifluoromethyl group as a novel N-1 substituent","volume":"48","author":"Asanhina","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib28","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s11095-013-1250-x","article-title":"Pharmacological characterization of 7-(4-(Piperazin-1-yl)) ciprofloxacin derivatives: antibacterial activity, cellular accumulation, susceptibility to efflux transporters, and intracellular activity","volume":"31","author":"Marquez","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejmech.2018.01.078_bib29","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1016\/j.bmc.2014.05.067","article-title":"Synthesis and antibacterial activity of catecholate-ciprofloxacin conjugates","volume":"22","author":"Fardeau","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib30","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1016\/j.bmcl.2011.07.060","article-title":"Preparation and antibacterial evaluation of decarboxylated fluoroquinolones","volume":"21","author":"Nguyen","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib31","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1021\/acsmedchemlett.5b00146","article-title":"Syntheses and antibacterial activity of N-Acylated ciprofloxacin derivatives based on the trimethyl lock","volume":"6","author":"Ji","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.01.078_bib32","doi-asserted-by":"crossref","first-page":"6513","DOI":"10.1016\/j.bmcl.2012.05.026","article-title":"Studies on the antimicrobial properties of N-acylated ciprofloxacins","volume":"22","author":"Cormier","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/cbdv.201400456","article-title":"Antibacterial activity of enrofloxacin and ciprofloxacin derivatives of \u03b2-octaarginine","volume":"12","author":"Purkayastha","year":"2015","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2018.01.078_bib34","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1016\/j.ejmech.2011.09.011","article-title":"Design, synthesis and antibacterial activity of fluoroquinolones containing bulky arenesulfonyl fragment: 2D-QSAR and docking study","volume":"46","author":"Abdel-Aziz","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib35","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.3390\/molecules18077557","article-title":"New 7-[4-(4-(un)Substituted)piperazine-1-carbonyl]piperazin-1-yl] derivatives of fluoroquinolone: synthesis and antimicrobial evaluation","volume":"18","author":"Chen","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.01.078_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jfluchem.2011.02.002","article-title":"Synthesis of N-aryl-2,2,2-trifluoroacetimidoyl piperazinylquinolone derivatives and their antibacterial evaluations","volume":"132","author":"Darehkordi","year":"2011","journal-title":"J.\u00a0Fluorine Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib37","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1016\/j.bmcl.2006.03.103","article-title":"Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety","volume":"16","author":"Foroumadi","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib38","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1016\/j.bmc.2015.06.009","article-title":"Potential antibacterial activity of triazine dendrimer: synthesis and controllable drug release properties","volume":"23","author":"Vembu","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib39","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.bmcl.2016.03.062","article-title":"Synthesis and molecular modeling of antimicrobial active fluoroquinolone-pyrazine conjugates with amino acid linkers","volume":"26","author":"Panda","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cbdd.12395","article-title":"Design, synthesis, antibacterial evaluation and docking study of novel 2-Hydroxy-3-(nitroimidazolyl)propyl-derived quinolone","volume":"85","author":"Li","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2018.01.078_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/14756366.2011.611943","article-title":"Synthesis and biological evaluation of novel benzothiazole clubbed fluoroquinolone derivatives","volume":"28","author":"Sharma","year":"2013","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib42","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/jhet.2760","article-title":"Conventional and microwave-assisted total synthesis, antioxidant capacity, biological activity, and molecular docking studies of new hybrid compounds","volume":"54","author":"Demirci","year":"2017","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib43","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1016\/j.ejmech.2011.04.035","article-title":"Synthesis, antibacterial evaluation and QSAR studies of 7-[4-(5-aryl-1,3,4-oxadiazole-2-yl)piperazinyl] quinolone derivatives","volume":"46","author":"Kumar","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib44","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00044-016-1526-x","article-title":"Synthesis, characterization and biological evaluation of some novel fluoroquinolones","volume":"25","author":"Pandit","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.01.078_bib45","first-page":"432","article-title":"Synthesis and in\u00a0vitro antibacterial activity of N-[5-(5-nitro-2-fyryl)-1,3,4-thiadiazole-2-yl] piperazinyl quinolone derivatives","volume":"58","author":"Foroumadi","year":"2003","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejmech.2018.01.078_bib46","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0223-5234(03)00148-X","article-title":"Synthesis and in\u00a0vitro antibacterial evaluation of N-[5-(5-nitro-2-thienyl)-1,3,4-thiadiazole-2-yl] piperazinyl quinolones","volume":"38","author":"Foroumadi","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib47","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0014-827X(03)00191-5","article-title":"Synthesis and in\u00a0vitro antibacterial activity of some N-(5-aryl-1,3,4-thiadiazole-2-yl)piperazinyl quinolone derivatives","volume":"58","author":"Foroumadi","year":"2003","journal-title":"Il Farmaco"},{"key":"10.1016\/j.ejmech.2018.01.078_bib48","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejmech.2016.08.031","article-title":"Design, synthesis and biological evaluation of ciprofloxacin tethered bis-1,2,3-triazole conjugates as potent antibacterial agents","volume":"124","author":"Kant","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib49","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1155\/2012\/340451","article-title":"Design, synthesis and docking studies of a novel ciprofloxacin analogue as an antimicrobial agent","volume":"9","author":"Jubie","year":"2012","journal-title":"E-J. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib50","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1016\/j.bmcl.2013.03.118","article-title":"Synthesis and biological evaluation of a class of quinolone triazoles as potential antimicrobial agents and their interactions with calf thymus DNA","volume":"23","author":"Cui","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib51","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejmech.2015.04.058","article-title":"Search for factors affecting antibacterial activity and toxicity of 1,2,4-triazole-ciprofloxacin hybrids","volume":"97","author":"Plech","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib52","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejmech.2012.11.040","article-title":"Synthesis and in\u00a0vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria","volume":"60","author":"Plech","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib53","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2174\/1570180813666161024165613","article-title":"Structure-based hybridization, conventional and microwave irradiated synthesis, biological evaluation and molecular docking studies of new compounds derived from thiomorpholin","volume":"14","author":"Demirci","year":"2017","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2018.01.078_bib54","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1016\/j.bmcl.2012.07.064","article-title":"Design, synthesis and evaluation of clinafloxacin triazole hybrids as a new type of antibacterial and antifungal agents","volume":"22","author":"Wang","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib55","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.cclet.2016.12.012","article-title":"Conventional and microwave irradiated synthesis, biological activity evaluation and molecular docking studies of highly substituted piperazine-azole hybrids","volume":"28","author":"Mermer","year":"2017","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.01.078_bib56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1515\/hc-2016-0125","article-title":"Synthesis and antimicrobial activity of new piperazine-based heterocyclic compounds","volume":"23","author":"Ozdemir","year":"2017","journal-title":"Heterocycl. Commun."},{"key":"10.1016\/j.ejmech.2018.01.078_bib57","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.3390\/molecules20046254","article-title":"Determination of the primary molecular target of 1,2,4-triazole-ciprofloxacin hybrids","volume":"20","author":"Plech","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.01.078_bib58","doi-asserted-by":"crossref","unstructured":"M. Mente\u015fe, F. \u015e. Beri\u015f, Demirba\u015f. Synthesis of Some New Ciprofloxacin Hybrids as Potential Antimicrobial Agents. J. Heterocycl. Chem. http:\/\/DOI:10.1002\/jhet.2907.","DOI":"10.1002\/jhet.2907"},{"key":"10.1016\/j.ejmech.2018.01.078_bib59","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1515\/hc-2016-0019","article-title":"Microwave-assisted and conventional synthesis of novel antimicrobial 1,2,4-triazole derivatives containing nalidixic acid skeleton","volume":"22","author":"Ceylan","year":"2016","journal-title":"Heterocycl. Commun."},{"key":"10.1016\/j.ejmech.2018.01.078_bib60","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1039\/C5MD00186B","article-title":"Design, synthesis, antibacterial evaluation of novel azolylthioether quinolones as MRSA DNA intercalators","volume":"6","author":"Zhang","year":"2015","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2018.01.078_bib61","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1155\/2012\/340451","article-title":"Design, synthesis and docking studies of a novel ciprofloxacin analogue as an antimicrobial agent","volume":"9","author":"Jubie","year":"2012","journal-title":"E-J. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib62","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.ejmech.2007.07.017","article-title":"4-Thiazolidinone-a biologically active scaffold","volume":"43","author":"Verma","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib63","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1016\/j.bmc.2012.03.069","article-title":"Recent developments and biological activities of thiazolidinone derivatives: a review","volume":"20","author":"Jain","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib64","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/cbdd.12299","article-title":"Discovery of the highly potent fluoroquinolone-based benzothiazolyl-4-thiazolidinone hybrids as antibacterials","volume":"84","author":"Patel","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2018.01.078_bib65","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijantimicag.2014.03.016","article-title":"Ecological impact of MCB3837 on the normal human microbiota","volume":"44","author":"Rashid","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2018.01.078_bib66","first-page":"767","article-title":"Analysis of effects of MCB3681, the antibacterially active substance of prodrug MCB3837, on human resident microflora as proof of principle","volume":"21","author":"Rashid","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejmech.2018.01.078_bib67","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1016\/j.bmcl.2003.07.021","article-title":"Novel oxazolidinone-quinolone hybrid antimicrobials","volume":"13","author":"Gordeev","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib68","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/S0968-0896(03)00083-X","article-title":"Design, synthesis and biological evaluation of oxazolidinone-quinolone hybrids","volume":"11","author":"Hubschwerlen","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib69","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1016\/j.bmcl.2004.07.064","article-title":"Synthesis and antibacterial activity of novel 6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-4-oxoquinoline-3-carboxylic acids bearing cyclopropane-fused 2-amino-8-azabicyclo[4.3.0]nonan-8-yl substituents at the C-7 position","volume":"14","author":"Inagaki","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib70","doi-asserted-by":"crossref","first-page":"6879","DOI":"10.1016\/j.bmc.2009.08.026","article-title":"Design, synthesis and biological evaluations of novel 7-[3-(1-aminocycloalkyl)pyrrolidin-1-yl]-6-desfluoro-8-methoxyquinolones with potent antibacterial activity against multi-drug resistant Gram-positive bacteria","volume":"17","author":"Miyauchi","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib71","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1016\/j.bmcl.2010.07.006","article-title":"Synthesis and in\u00a0vitro antibacterial activity of novel fluoroquinolone derivatives containing substituted piperidines","volume":"20","author":"Chai","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib72","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1016\/j.bmcl.2015.07.010","article-title":"Synthesis of ciprofloxacin dimers for evaluation of bacterial permeability in atypical chemical space","volume":"25","author":"Ross","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib73","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF02464368","article-title":"Synthesis and turbeculostatic activity of podads with gluoroquinolone gragments","volume":"31","author":"Fedorova","year":"1997","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejmech.2018.01.078_bib74","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/j.bmcl.2015.07.077","article-title":"Novel antibacterial active quinolone-fluoroquinolone conjugates and 2D-QSAR studies","volume":"25","author":"Panda","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib75","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1128\/AAC.48.6.2108-2115.2004","article-title":"Ciprofloxacin dimers target gyrase in Streptococcus pneumonia","volume":"48","author":"Gould","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.01.078_bib76","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.diagmicrobio.2005.11.004","article-title":"Susceptibility studies of piperazinyl cross-linked fluoroquinolone dimers against test strains of Gram-positive and Gram-negative bacteria","volume":"54","author":"Kerns","year":"2006","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejmech.2018.01.078_bib77","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0960-894X(03)00208-7","article-title":"Piperazinyl-linked fluoroquinolone dimers possessing potent antibacterial activity against drug-resistant strains of Staphylococcus aureus","volume":"13","author":"Kerns","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib78","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/S0960-894X(03)00376-7","article-title":"Structural features of piperazinyl-linked ciprofloxacin dimers required for activity against drug-resistant strains of Staphylococcus aureus","volume":"13","author":"Kerns","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib79","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jhet.2391","article-title":"Design, synthesis and evaluation of antibacterial effects of a new class of piperazinylquinolone derivatives","volume":"53","author":"Darehkordi","year":"2016","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib80","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/bjs.4644","article-title":"Bisphosphonate-ciprofloxacin bound to Skelite\u2122 is a prototype for enhancing experimental local antibiotic delivery to injured bone","volume":"91","author":"Buxton","year":"2004","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.ejmech.2018.01.078_bib81","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1021\/jm0105326","article-title":"Osteoadsorptive bisphosphonate derivatives of fluoroquinolone antibacterials","volume":"45","author":"Herczegh","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib82","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1021\/acs.jmedchem.6b01615","article-title":"Design, synthesis, and antimicrobial evaluation of a novel bone-targeting bisphosphonate-ciprofloxacin conjugate for the treatment of osteomyelitis biofilms","volume":"60","author":"Sedghizadeh","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib83","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ejmech.2011.10.049","article-title":"Synthesis of osteotropic hydroxybisphosphonate derivatives of fluoroquinolone antibacterials","volume":"47","author":"McPherson","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib84","doi-asserted-by":"crossref","first-page":"9343","DOI":"10.1021\/jm500613m","article-title":"Hybrids of phenylsulfonylfuroxan and coumarin as potent antitumor agents","volume":"57","author":"Liu","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib85","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejmech.2014.07.087","article-title":"Synthesis, biological evaluation and molecular docking of novel chalcone-coumarin hybrids as anticancer and antimalarial agents","volume":"85","author":"Pingaew","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib86","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2174\/1570180811666141009234835","article-title":"The novel derivatives of 3-(iminomethyl)-2H-chromen-2-one with thiourea and piperazine structural motive: rationale, synthesis, antimicrobial and anti-TB evaluation","volume":"12","author":"Lakum","year":"2015","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2018.01.078_bib87","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejmech.2014.08.025","article-title":"Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: structure based design, synthesis, SAR and antimicrobial activity","volume":"86","author":"Yule","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib88","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejmech.2015.11.027","volume":"108","author":"Ji","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib89","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ardp.200700090","article-title":"Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety","volume":"341","author":"Emami","year":"2008","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejmech.2018.01.078_bib90","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejmech.2014.04.037","article-title":"Design, synthesis, and evaluation of novel fluoroquinolone-flavonoid hybrids as potent antibiotics against drug-resistant microorganisms","volume":"80","author":"Xiao","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib91","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1016\/j.bmc.2014.05.018","article-title":"Novel 3-arylfuran-2(5H)-one-fluoroquinolone hybrid: design, synthesis and evaluation as antibacterial agent","volume":"22","author":"Wang","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib92","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1211\/146080800128736196","article-title":"Synthesis and in\u00a0vitro antibacterial activity of N-piperazinyl quinolone derivatives with a 2-thienyl group","volume":"6","author":"Mirzaei","year":"2000","journal-title":"Pharm. Pharmacol. Commun."},{"key":"10.1016\/j.ejmech.2018.01.078_bib93","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1248\/cpb.55.894","article-title":"Synthesis and antibacterial activity of new N-[2-(Thiophen-3-yl)ethyl] piperazinyl quinolones","volume":"55","author":"Letafat","year":"2007","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2018.01.078_bib94","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1211\/146080899128734181","article-title":"Synthesis and in-vitro antibacterial activity of new N-Substituted piperazinyl quinolones","volume":"5","author":"Foroumadi","year":"1999","journal-title":"Pharm. Pharmacol. Commun."},{"key":"10.1016\/j.ejmech.2018.01.078_bib95","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ardp.200600169","article-title":"Synthesis and antibacterial activity of new 7-piperazinylquinolones containing a functionalized 2-(Furan-3-yl)ethyl moiety","volume":"340","author":"Foroumadi","year":"2007","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejmech.2018.01.078_bib96","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejmech.2016.03.086","article-title":"Synthesis and biological evaluation of novel structural hybrids of benzofuroxan derivatives and fluoroquinolones","volume":"116","author":"Chugunova","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib97","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1007\/s00044-013-0581-9","article-title":"7-Piperazinylquinolones with methylene-bridged nitrofuran scaffold as new antibacterial agents","volume":"22","author":"Emami","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.01.078_bib98","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1016\/j.bmc.2005.12.058","article-title":"Synthesis and antibacterial activity of N-[2-[5-(methylthio)thiophen-2-yl]-2-oxoethyl] and N-[2-[5-(methylthio)thiophen-2-yl]-2-(oxyimino)ethyl]piperazinylquinolone derivatives","volume":"14","author":"Formoumadi","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib99","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1016\/j.bmcl.2005.07.005","article-title":"Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2-oxoethyl] and N-[(2-5-bromothiophen-2-yl)-2-oximinoethyl] derivatives of piperazinyl quinolones","volume":"15","author":"Foroumadi","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib100","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1016\/j.bmc.2004.08.028","article-title":"Design, synthesis and biological evaluation of novel non-nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum chemotherapeutic properties","volume":"12","author":"Sriram","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib101","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0223-5234(00)00125-2","article-title":"Synthesis, antibacterial, antifungal and anti-HIV activities of norfloxacin Mannich bases","volume":"35","author":"Pandeya","year":"2000","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib102","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00044-005-0135-x","article-title":"Synthesis, antiviral and antibacterial activities of isatin mannich bases","volume":"14","author":"Sriram","year":"2005","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.01.078_bib103","first-page":"103","article-title":"Synthesis, antibacterial, antifungal and anti-HIV evaluation of Norfloxacin mannich bases","volume":"67","author":"Pandeya","year":"1999","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.ejmech.2018.01.078_bib104","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.farmac.2005.03.005","article-title":"Newer aminopyrimidinimino isatin analogues as non-nucleoside HIV-1 reverse transcriptase inhibitors for HIV and other opportunistic infections of AIDS: design, synthesis and biological evaluation","volume":"60","author":"Sriram","year":"2005","journal-title":"Il Farmaco"},{"key":"10.1016\/j.ejmech.2018.01.078_bib105","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1021\/acs.jmedchem.6b00485","article-title":"Development of a dual-acting antibacterial agent (TNP-2092) for the treatment of persistent bacterial infections","volume":"59","author":"Ma","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib106","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1021\/jm900028n","article-title":"Design, synthesis, and evaluation of novel fluoroquinolone-aminoglycoside hybrid antibiotics","volume":"52","author":"Pokrovskaya","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib107","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejmech.2013.05.003","article-title":"Design and synthesis of biquinolone-isoniazid hybrids as a new class of antitubercular and antimicrobial agents","volume":"65","author":"Jardosh","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib108","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.bmc.2017.02.068","article-title":"Covalently linked kanamycin-Ciprofloxacin hybrid antibiotics as a tool to fight bacterial resistance","volume":"25","author":"Shavit","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib109","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejmech.2013.07.032","article-title":"Mannich bases of 7-piperazinylquinolones and kojic acid derivatives: synthesis, in\u00a0vitro antibacterial activity and in silico study","volume":"68","author":"Emami","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib110","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1016\/j.bmcl.2010.04.062","article-title":"Novel 8a-aza-8a-homoerythromycin-4\u2019\u2019-(3-substituted-amino)propionates with broad spectrum antibacterial activity","volume":"20","author":"Hutinec","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib111","doi-asserted-by":"crossref","first-page":"8566","DOI":"10.1016\/j.bmc.2010.10.024","article-title":"Novel hybrids of 15-membered 8a- and 9a-azahomoerythromycin A ketolides and quinolones as potent antibacterials","volume":"18","author":"Pavlovi\u0107","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib112","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejmech.2016.09.022","article-title":"Synthesis of novel 15-membered 8a-azahomoerythromycin a acylides: consequences of structural modification at the C-3 and C-6 position on antibacterial activity","volume":"125","author":"Pavlovi\u0107","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib113","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1021\/jm0510023","article-title":"Hybrid antibacterials. DNA polymerase-topoisomerase inhibitors","volume":"49","author":"Zhi","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib114","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/AAC.01311-05","volume":"51","author":"Butler","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.01.078_bib115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF02098092","article-title":"Synergism of trimethoprim and ciprofloxacin in\u00a0vitro against clinical bacterial isolates","volume":"11","author":"Huovinen","year":"1992","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejmech.2018.01.078_bib116","doi-asserted-by":"crossref","first-page":"9244","DOI":"10.1021\/ja402326z","article-title":"Bifunctional unnatural sialic acids for dual metabolic labeling of cell-surface sialylated glycans","volume":"135","author":"Feng","year":"2013","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.01.078_bib117","doi-asserted-by":"crossref","first-page":"461","DOI":"10.6023\/cjoc201309032","article-title":"Progress in the synthesis of sialic acid derivatives","volume":"34","author":"Wang","year":"2014","journal-title":"Chin. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib118","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1021\/jm990015b","article-title":"Glycosylation of fluoroquinolones through direct and oxygenated polymethylene linkages as a sugar-mediated active transport system for antimicrobials","volume":"42","author":"Jung","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib119","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/cbic.201300512","article-title":"Probing bacterial uptake of glycosylated ciprofloxacin conjugates","volume":"15","author":"Milner","year":"2014","journal-title":"ChemBioChem"},{"key":"10.1016\/j.ejmech.2018.01.078_bib120","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/anie.201508330","article-title":"Adjuvants based on hybrid antibiotics overcome resistance in Pseudomonas aeruginosa and enhance fluoroquinolone efficacy","volume":"55","author":"Gorityala","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2018.01.078_bib121","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.bmc.2017.02.068","article-title":"Covalently linked kanamycin-Ciprofloxacin hybrid antibiotics as a tool to fight bacterial resistance","volume":"25","author":"Shavit","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib122","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.bmc.2007.11.052","article-title":"Glyconanobiotics: novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis","volume":"16","author":"Abeylath","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib123","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1021\/jm900028n","article-title":"Design, synthesis, and evaluation of novel fluoroquinolone-aminoglycoside hybrid antibiotics","volume":"52","author":"Pokrovskaya","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib124","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.bmcl.2009.01.007","article-title":"Synthesis of citrate-ciprofloxacin conjugates","volume":"19","author":"Md-Saleh","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib125","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1016\/j.bmc.2014.04.009","article-title":"Probing linker design in citric acid-ciprofloxacin conjugates","volume":"22","author":"Milner","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib126","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.bmcl.2014.01.065","article-title":"Synthesis and antibacterial evaluation of amino acid-antibiotic conjugates","volume":"24","author":"Ibrahim","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib127","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.ejmech.2008.01.042","article-title":"Synthesis and evaluation of fluoroquinolone derivatives as substrate-based inhibitors of bacterial efflux pumps","volume":"43","author":"German","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib128","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00706-010-0263-y","article-title":"Synthesis of a dihydrotestosterone-ciprofloxacin conjugate: relationship between descriptors logP, p, Rm, and Vm and its antibacterial activity in S. aureus and E. coli","volume":"141","author":"Figueroa-Valverde","year":"2010","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejmech.2013.07.032","article-title":"Mannich bases of 7-piperazinylquinolones and kojic acid derivatives: synthesis, in\u00a0vitro antibacterial activity and in silico study","volume":"68","author":"Emami","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib130","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ejmech.2017.06.058","article-title":"Ciprofloxacin-nitroxide hybrids with potential for biofilm control","volume":"138","author":"Verderosa","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib131","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1039\/c3nj01243c","article-title":"Phosphine derivatives of ciprofloxacin and norfloxacin, a new class of potential therapeutic agents","volume":"38","author":"Bykowska","year":"2014","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib132","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1021\/acs.bioconjchem.5b00393","article-title":"Conjugation of ciprofloxacin with poly(2-oxazoline)s and polyethylene glycol via end groups","volume":"26","author":"Schmidt","year":"2015","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib133","doi-asserted-by":"crossref","first-page":"8288","DOI":"10.1039\/c1ob06250f","article-title":"Synthesis and biological properties of conjugates between fluoroquinolones and a N3\u2019\u2019-functionalized pyochelin","volume":"9","author":"N\u00f6el","year":"2011","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib134","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1021\/ml300150y","article-title":"Syntheses of siderophore-drug conjugates using a convergent thiol-maleimide system","volume":"3","author":"Ju\u00e1rez-Hern\u00e1ndez","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.01.078_bib135","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1021\/bc300610f","article-title":"Trihydroxamate siderophore-fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus","volume":"24","author":"Wencewicz","year":"2013","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib136","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1016\/j.bmcl.2015.02.034","article-title":"Evaluation of (acyloxy)alkyl ester linkers for antibiotic release from siderophore-antibiotic conjugates","volume":"25","author":"Zheng","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.078_bib137","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1039\/c3ob40162f","article-title":"Staphyloferrin A as siderophore-component in fluoroquinolone-based Trojan horse antibiotics","volume":"11","author":"Milner","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib138","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1021\/jm400265k","article-title":"Biscatecholate-monohydroxamate mixed ligand siderophore-carbacephalosporin conjugates are selective sideromycin antibiotics that target acinetobacter baumannii","volume":"56","author":"Wencewicz","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib139","doi-asserted-by":"crossref","first-page":"18388","DOI":"10.1021\/ja3077268","article-title":"Siderophore-Mediated cargo delivery to the cytoplasm of Escherichia coli and Pseudomonas aeruginosa: syntheses of monofunctionalized enterobactin scaffolds and evaluation of enterobactin-cargo conjugate uptake","volume":"134","author":"Zheng","year":"2012","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.01.078_bib140","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00044-009-9228-2","article-title":"Synthesis and antimicrobial study of fluoroquinolone-based 4-thiazolidinones","volume":"19","author":"Patel","year":"2010","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.01.078_bib141","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1039\/c0md00082e","volume":"1","author":"Matos","year":"2010","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2018.01.078_bib142","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molstruc.2010.01.036","volume":"969","author":"Sultana","year":"2010","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2018.01.078_bib143","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.inoche.2011.10.037","article-title":"DNA interaction and in-vitro antibacterial studies of fluoroquinolone based platinum(II) complexes","volume":"15","author":"Patel","year":"2015","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.ejmech.2018.01.078_bib144","first-page":"622","article-title":"Synthesis, characterization and biological activities of ciprof loxacin drug based metal complexes","volume":"59","author":"Patel","year":"2012","journal-title":"Acta Chim. Slov."},{"key":"10.1016\/j.ejmech.2018.01.078_bib145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.inoche.2012.10.018","volume":"27","author":"Patel","year":"2013","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.ejmech.2018.01.078_bib146","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.saa.2010.11.056","article-title":"Synthesis, characterization, antibacterial activity, SOD mimic and interaction with DNA of drug based copper(II) complexes","volume":"78","author":"Patel","year":"2011","journal-title":"Spectrochim. Acta, Part A"},{"key":"10.1016\/j.ejmech.2018.01.078_bib147","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00706-013-1086-4","article-title":"DNA interactions and promotion in antibacterial activities of the norfloxacin drug due to formation of mixed-ligand copper(II) complexes","volume":"145","author":"Patel","year":"2014","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib148","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.saa.2012.05.037","article-title":"Interaction of drug based copper(II) complexes with Herring Sperm DNA and their biological activities","volume":"97","author":"Patel","year":"2012","journal-title":"Spectrochim. Acta, Part A"},{"key":"10.1016\/j.ejmech.2018.01.078_bib149","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.saa.2012.11.045","article-title":"Cytotoxic, antibacterial, DNA interaction and superoxide dismutase like activities of sparfloxacin drug based copper(II) complexes with nitrogen donor ligands","volume":"104","author":"Patel","year":"2013","journal-title":"Spectrochim. Acta, Part A"},{"key":"10.1016\/j.ejmech.2018.01.078_bib150","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s00044-016-1503-4","article-title":"Metal-based biologically active compounds: design, synthesis, medicinal, toxicity and DNA interaction assay","volume":"25","author":"Gajera","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.01.078_bib151","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jinorgbio.2016.02.026","article-title":"Synthesis, characterization, and evaluation of the antimicrobial potential of copper(II) coordination complexes with quinolone and p-xylenyl-linked quinolone ligands","volume":"162","author":"Mjos","year":"2016","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib152","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0162-0134(03)00123-5","volume":"95","author":"Turel","year":"2003","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2018.01.078_bib153","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s00044-016-1503-4","article-title":"Metal-based biologically active compounds: design, synthesis, medicinal, toxicity and DNA interaction assay","volume":"25","author":"Gajera","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.01.078_bib154","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.saa.2014.02.087","article-title":"Interaction of vanadium (IV) solvates (L) with second-generation fluoroquinolone antibacterial drug ciprofloxacin: spectroscopic, structure, thermal analyses, kinetics and biological evaluation (L= An, DMF, Py and Et3N)","volume":"129","author":"Zordok","year":"2014","journal-title":"Spectrochim. Acta, Part A"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418300977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418300977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T19:28:55Z","timestamp":1719775735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418300977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":154,"alternative-id":["S0223523418300977"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.078","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ciprofloxacin derivatives and their antibacterial activities","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}